Citius Oncology, Inc.
CTOR · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25 | -$21 | -$13 | -$5 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $1 | $1 | $1 | $1 |
| Stock-Based Comp. | $8 | $7 | $2 | $0 |
| Change in WC | $10 | $13 | $10 | $5 |
| Other Non-Cash | $0 | $0 | -$1 | -$0 |
| Operating Cash Flow | -$5 | $0 | -$1 | -$0 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$1 | -$67 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$5 | $0 | $0 |
| Investing Cash Flow | -$6 | -$5 | -$1 | -$67 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $4 | $0 | $0 |
| Stock Issued | $15 | $0 | $0 | $68 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $1 | $2 | -$0 |
| Financing Cash Flow | $15 | $5 | $2 | $68 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4 | $0 | -$0 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $0 | $0 | $0 |
| End Cash | $4 | $0 | $0 | $0 |
| Free Cash Flow | -$11 | -$5 | -$1 | -$0 |